|
|
Linnegatan 89 B
Stockholm, SE-115 23 Sweden
phone:+46 8 661 00 26
fax:+46 8 661 63 68
|
|
| Symbol |
DIAM B |
| Exchange |
STO |
| Founded |
0 |
| Employees |
|
|
|
| www.diamyd.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Identify potential therapeutics for their development through Phase II clinical trials. |
|
| Management |
| Anders Essen-M?ller, Chairman. M.Sc. Founder and former CEO; Elisabeth Lindner, President and CEO; Darren Wolfe, CEO of Diamyd; Erika Hillborg, Director of Clinical Trials; Peter Zerhouni, Director of Business Development |
| |
|
|
|
|
|
|
|
| Keywords |
| metabolic, immunology, autoimmune, inflammation, pharmaceutical, diagnostic, allergyimmunology |
|
|
|
| Description |
|
Diamyd Medical uses its competence and contact network within immunology, biotechnology and business development to identify and develop pharmaceutical projects through Phase II clinical trials. Thereafter, partnering will be sought with larger pharmaceutical companies for further commercialization. Development and marketing of related diagnostic tests and reagents may be undertaken to promote contact with researchers and to prepare the market for subsequent pharmaceutical product launches. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
